FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sumatriptan Succinate (Imitrex) Injection
Status: Discontinuation
»Therapeutic Categories: Neurology

GlaxoSmithKline (New 04/03/2020)

Company Contact Information:
888-825-5249

Presentation Posting Date Related Information
6 mg, single dose vial (NDC 0173-0449-02) 04/03/2020 A business decision was made to discontinue manufacture of the drug product. The anticipated date that GSK will cease distribution of the product is approximately August 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English